|
|
|
|
| LEADER |
00000nam a2200000 c 4500 |
| 001 |
1819451585 |
| 003 |
DE-627 |
| 005 |
20221020114600.0 |
| 007 |
tu |
| 008 |
221020s2018 gw ||||| m 00| ||eng c |
| 035 |
|
|
|a (DE-627)1819451585
|
| 035 |
|
|
|a (DE-599)KXP1819451585
|
| 035 |
|
|
|a (OCoLC)1348284580
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a eng
|
| 044 |
|
|
|c XA-DE-BW
|
| 082 |
0 |
|
|a 616.994
|q DE-101
|
| 082 |
0 |
4 |
|a 610
|q DE-101
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 100 |
1 |
|
|a Nasrh, Mohamed Hassan Atia Hassan
|d 1984-
|e VerfasserIn
|0 (DE-588)1268874272
|0 (DE-627)1817394223
|4 aut
|
| 245 |
1 |
0 |
|a Impact of anti-cancer drugs on antibody-based complement-mediated tumor cell killing
|c vorgelegt von Mohamed Hassan Atia Hassan Nasrh ; Doktorvater: Prof. Dr. med. vet. Michael Kirschfink
|
| 264 |
|
1 |
|a Heidelberg
|c 2018
|
| 300 |
|
|
|a 1 Band (verschiedene Seitenzählungen)
|b Illustrationen, Diagramme
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 502 |
|
|
|b Dissertation
|c Ruprecht-Karls-Universität Heidelberg
|d 2022
|
| 546 |
|
|
|a Text Englisch, Zusammenfassung in deutscher und englischer Sprache
|
| 655 |
|
7 |
|a Hochschulschrift
|0 (DE-588)4113937-9
|0 (DE-627)105825778
|0 (DE-576)209480580
|2 gnd-content
|
| 700 |
1 |
|
|a Kirschfink, Michael
|e AkademischeR BetreuerIn
|0 (DE-588)120927152
|0 (DE-627)080974457
|0 (DE-576)292452411
|4 dgs
|
| 710 |
2 |
|
|a Universität Heidelberg
|e Grad-verleihende Institution
|0 (DE-588)2024349-2
|0 (DE-627)102161488
|0 (DE-576)191769517
|4 dgg
|
| 751 |
|
|
|a Heidelberg
|0 (DE-588)4023996-2
|0 (DE-627)106300814
|0 (DE-576)208952578
|4 uvp
|
| 776 |
0 |
8 |
|i Erscheint auch als
|n Online-Ausgabe
|a Nasrh, Mohamed Hassan Atia Hassan, 1984 -
|t Impact of anti-cancer drugs on antibody-based complement-mediated tumor cell killing
|d Heidelberg : Universitätsbibliothek Heidelberg, 2022
|h 1 Online-Ressource (v, 118, [41] Seiten)
|w (DE-627)181606601X
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20221024
|
| 993 |
|
|
|a Thesis
|
| 998 |
|
|
|g 1268874272
|a Nasrh, Mohamed Hassan Atia Hassan
|m 1268874272:Nasrh, Mohamed Hassan Atia Hassan
|d 50000
|d 51001
|e 50000PN1268874272
|e 51001PN1268874272
|k 0/50000/
|k 1/50000/51001/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN1819451585
|e 4201316033
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"recId":"1819451585","language":["eng"],"corporate":[{"display":"Universität Heidelberg","roleDisplay":"Grad-verleihende Institution","role":"dgg"}],"type":{"bibl":"thesis"},"title":[{"title_sort":"Impact of anti-cancer drugs on antibody-based complement-mediated tumor cell killing","title":"Impact of anti-cancer drugs on antibody-based complement-mediated tumor cell killing"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Nasrh, Mohamed Hassan Atia Hassan","given":"Mohamed Hassan Atia Hassan","family":"Nasrh"},{"family":"Kirschfink","given":"Michael","display":"Kirschfink, Michael","roleDisplay":"AkademischeR BetreuerIn","role":"dgs"}],"noteThesis":["Dissertation. - Ruprecht-Karls-Universität Heidelberg. - 2022"],"physDesc":[{"extent":"1 Band (verschiedene Seitenzählungen)","noteIll":"Illustrationen, Diagramme"}],"id":{"eki":["1819451585"]},"origin":[{"publisherPlace":"Heidelberg","dateIssuedDisp":"2018","dateIssuedKey":"2018"}],"name":{"displayForm":["vorgelegt von Mohamed Hassan Atia Hassan Nasrh ; Doktorvater: Prof. Dr. med. vet. Michael Kirschfink"]}}
|
| SRT |
|
|
|a NASRHMOHAMIMPACTOFAN2018
|
